EYE DISORDERS CONGENITAL
Clinical trials for EYE DISORDERS CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new EYE DISORDERS CONGENITAL trials appear
Sign up with your email to follow new studies for EYE DISORDERS CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental eye injection aims to slow blindness in genetic vision disorder
Disease control Recruiting nowThis study is testing whether an experimental drug called ultevursen, given as an injection into the eye, can slow the progression of vision loss in people with retinitis pigmentosa caused by specific mutations in the USH2A gene. The trial will enroll 81 participants, who will be…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Breakthrough eye injection trial offers hope for children born blind
Disease control Recruiting nowThis study is testing whether regular eye injections of an experimental drug called sepofarsen can improve vision in people with a specific genetic form of Leber congenital amaurosis (LCA), which causes severe vision loss from childhood. In this carefully designed trial, each par…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE3 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC